Transdiagnostic Brain-Behavior Profiling to Enhance Cognitive Behavioral Therapy Response
Не применимо
Завершено
NCT03175068
| Заболевание | Major Depressive Disorder, Social Anxiety Disorder |
|---|
| Фаза | Не применимо |
|---|
| Спонсор | University of Illinois at Chicago |
|---|
| Статус | Завершено |
|---|
| Участники | 203 участн. |
|---|
| Вмешательство | CBT, ST |
|---|
| Дата начала | 5.07.2017 |
|---|
| Дата завершения | 1.03.2022 |
|---|
| Публикация результатов | 23.06.2026 |
|---|
Кратко
Many patients with Major Depressive Disorder (MDD) and generalized Social Anxiety Disorder (gSAD) are treated with cognitive behavioral therapy (CBT) but few have meaningful improvement. MDD and gSAD are diseases of brain dysfunction that manifest as impaired emotion regulation; CBT teaches emotion regulation strategies but how it works in the brain remains largely unknown. Individual differences in brain function related to emotion regulation may make some patients better suited for CBT and CBT may remedy the brain dysfunction that underlies these disorders. This project will compare CBT with a placebo psychotherapy (i.e., supportive therapy) in MDD and gSAD to test, validate, and refine brain-based markers and examine mechanisms of change to examine how CBT works and for whom.
Changes in Symptom Severity From Baseline to Week 12 Between Treatment Arms
baseline and week 12 · units on a scale
| Control | .05 ± .06 units on a scale |
|---|
| Cognitive Behavioral Therapy | 0.884 ± 0.254 units on a scale |
|---|
| Supportive Therapy | 0.869 ± 0.261 units on a scale |
|---|
| Control | .04 ± .05 units on a scale |
|---|
| Cognitive Behavioral Therapy | 0.482 ± 0.299 units on a scale |
|---|
| Supportive Therapy | 0.601 ± 0.321 units on a scale |
|---|
| p-value | <.05 |
| Mean Difference (Final Values) | .01 |
Baseline Brain Activity During Emotion Regulation Differences Between Controls and Patients
baseline · arbitrary units
| Control | .33 ± .91 arbitrary units |
|---|
| Cognitive Behavioral Therapy | .60 ± .69 arbitrary units |
|---|
| Supportive Therapy | .39 ± .54 arbitrary units |
|---|
| Control | .31 ± .98 arbitrary units |
|---|
| Cognitive Behavioral Therapy | .52 ± .74 arbitrary units |
|---|
| Supportive Therapy | .38 ± .57 arbitrary units |
|---|
| p-value | >.05 |
| Mean Difference (Final Values) | .04 |
Comparisons Between Emotion Regulation Task Brain Activity at Baseline and After Completing Therapy (12 Weeks).
baseline and 12 weeks · arbitrary units
| Control | .27 ± 1.10 arbitrary units |
|---|
| Cognitive Behavioral Therapy | .61 ± .63 arbitrary units |
|---|
| Supportive Therapy | .36 ± .49 arbitrary units |
|---|
| Control | .23 ± .64 arbitrary units |
|---|
| Cognitive Behavioral Therapy | .47 ± .60 arbitrary units |
|---|
| Supportive Therapy | .44 ± .51 arbitrary units |
|---|
| p-value | >.05 |
| Mean Difference (Final Values) | .33 |
Открыть в BENITIONS
Открыть на ClinicalTrials.gov
Другие исследования по этому заболеванию
Все исследования
Страница обобщает открытые данные ClinicalTrials.gov. Это не медицинская и не инвестиционная рекомендация. Обратитесь к врачу.